Eternity Biotech Launches Crowdfunding Campaign on Wefunder to Accelerate Anti-Aging Product Development
2024-04-02
NEW YORK, April 2, 2024 /PRNewswire/ -- Eternity Biotech, Inc. (the "Company", "Eternity"), a biotechnology company dedicated to finding solutions for longer, healthier lives, today announced the launch of a crowdfunding campaign on Wefunder to advance its anti-aging product development.
A spin out from Yale University, Eternity's revolutionary approach hinges on targeted expression of genes identified in the nematode worm that play significant roles in cell division and protection from stress. Through precision microinjection techniques focused on these genes, Yale researchers were able to increase the lifespan of nematodes by 25% and increased their ability to confront and conquer stressors such as oxidative challenges, apoptosis, and DNA damage. After replicating these results in human cells, Eternity looks to develop this technology and identify a novel candidate in the anti-aging space.
"With this campaign, we look to usher in a new era of growth and development for Eternity and within the broader anti-aging sector of life science research," said Joseph Hernandez, Chairman and Chief Executive Officer of Eternity. "The exciting part about this platform is that it allows investors of all sizes and backgrounds to get involved in biotech investing while simultaneously supporting our mission and company growth. We are thrilled to welcome our new investors and strive towards longer, healthier lives for all."
The Company is 'testing the waters' to gauge investor interest in an offering under Regulation Crowdfunding. No money or other consideration is being solicited. If sent, it will not be accepted. No offer to buy securities will be accepted. No part of the purchase price will be received until a Form C is filed and only through Wefunder's platform. Any indication of interest involves no obligation or commitment of any kind.
For media inquiries, please contact [email protected].
About Eternity Biotech, Inc.
Emanating from the distinguished research laboratories of Yale University, the very essence of Eternity Biotech is grounded in the belief that human experience can transcend its traditional boundaries. We envision a world where aging is not an inevitability, but a challenge to be met with cutting-edge technology and innovative solutions. Through dedicated research and development, we have identified genes that play a key role in cell division and protection from stressors, proved both in a nematode model and in human cells. Our mission is to further develop this technology into an effective solution to combat aging for all. To learn more about our mission and technology, visit our website at www.eternitybio.com and follow us on LinkedIn for news and updates.
SOURCE Eternity Biotech, Inc.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。